Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04963556
Other study ID # 2017-01079
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 18, 2017
Est. completion date April 15, 2018

Study information

Verified date July 2021
Source University of Basel
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: The consumption of Energy Drinks (EDs) can acutely lead to negative side effects, such as raised blood pressure and impaired endothelial function. Nevertheless, they are sold worldwide and are often consumed before physical activity (PA). In contrast to the blood pressure elevating effect of EDs, PA leads to a reduction of blood pressure. The effect of ED consumption on blood pressure response during and after endurance training is currently unresolved. Methods: A total of 23 participants (eleven men, twelve women) were evaluated in the intervention study with a blinded Cross-Over Design. They consumed on two different days either 355 ml Red Bull (RB) or 355 ml Placebo (Pla) in randomised order. The peripheral (PBP) and central blood pressure (CBP) were measured before, during and after a 30-minute aerobic endurance training, by the Schiller BR-102 plus PWA device.


Description:

Background: The consumption of Energy Drinks (EDs) can acutely lead to negative side effects, such as raised blood pressure and impaired endothelial function. Nevertheless, they are sold worldwide and are often consumed before physical activity (PA). In contrast to the blood pressure elevating effect of EDs, PA leads to a reduction of blood pressure. The effect of ED consumption on blood pressure response during and after endurance training is currently unresolved. Methods: A total of 23 participants (eleven men, twelve women) were evaluated in the intervention study with a blinded Cross-Over Design. They consumed on two different days either 355 ml Red Bull (RB) or 355 ml Placebo (Pla) in randomised order. The peripheral (PBP) and central blood pressure (CBP) were measured before, during and after a 30-minute aerobic endurance training, by the Schiller BR-102 plus PWA device.


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date April 15, 2018
Est. primary completion date November 1, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - No known cardiovascular diseases such as arterial hypertension and diabetes mellitus. - No ophthalmological diseases such as glaucoma or macular degeneration. - No regular medication - No vasodilator abuse for 24 h before the respective intervention (e.g. smoking, use of stimulants, ß-blockers). - No pregnancy (anamnestic)

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Red Bull
Drinking of Red Bull before exercise

Locations

Country Name City State
Switzerland University of Basel Basel

Sponsors (1)

Lead Sponsor Collaborator
University of Basel

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effect on blood pressure Effect on systolic and diastolic blood pressure 24 hours
Secondary Pulse wave velocity central pulse wave velocity 24 hours
See also
  Status Clinical Trial Phase
Not yet recruiting NCT01643096 - The Effect of Thyme and Sumac on the Thermic Effect of Food and Comparison Between Warm and Cold Temperament People N/A